Life sciences companies will face a new set of challenges in a post-Covid-19 world. Whether you’re an investor in a life sciences company, a contract development and manufacturing organization, CSO (Chief Scientific Officer) or the CEO, you’ll have concerns about how the “new normal” will affect your business operations. For...
Read More
As the economy in the United States reopens following weeks of widespread stay-at-home orders, don’t expect a quick return to “business as usual.” Reopening requires a lot more than just flipping a switch. More than 73% of U.S. companies have not yet created a return-to-work strategy, according to a survey...
Read More
Foa & Son is pleased to welcome Michael Pearl to our team. He's heading up the Jewelry, Fine Art & Specie practice at Foa & Son, and his expertise couldn't have come at a better time. Michael is an expert in specie insurance. Specie insurance covers precious and valuable items anywhere in the world...
Read More
“I hope this message finds you well”. Something I have said thousands of times in the past. Never before, have these words meant to much. Our lives have changed, and we all face an incredible challenge. Similar to a CAT 5 hurricane, we heard news of COVID-19 approaching. While some...
Read More
By Michael Lieberman -- As the spread of COVID-19 continues to disrupt global supply chains, many owners of food and beverage businesses are wondering whether their commercial insurance programs will reimburse them for lost revenues. Lost revenues can stem from not being able to receive an international shipment, to not...
Read More
We’re seeing more and more clients impacted by coronavirus shutdowns. Inevitably that begs the question: does my business have coverage? An article in Insurance Journal discusses various coverage theories that may be applicable to coronavirus related losses. The article states that many claims are being filed, but there are major...
Read More